Neomenthoglycol

Details

Top
Internal ID e033fcae-54fb-4a7b-920e-8e1bca7a5190
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Monoterpenoids > Menthane monoterpenoids
IUPAC Name (1S,2R,5R)-2-(2-hydroxypropan-2-yl)-5-methylcyclohexan-1-ol
SMILES (Canonical) CC1CCC(C(C1)O)C(C)(C)O
SMILES (Isomeric) C[C@@H]1CC[C@H]([C@H](C1)O)C(C)(C)O
InChI InChI=1S/C10H20O2/c1-7-4-5-8(9(11)6-7)10(2,3)12/h7-9,11-12H,4-6H2,1-3H3/t7-,8-,9+/m1/s1
InChI Key LMXFTMYMHGYJEI-HLTSFMKQSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C10H20O2
Molecular Weight 172.26 g/mol
Exact Mass 172.146329876 g/mol
Topological Polar Surface Area (TPSA) 40.50 Ų
XlogP 2.20
Atomic LogP (AlogP) 1.55
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 1

Synonyms

Top
3564-95-2
Cis-p-menthane-3,8-diol
92471-23-3
(1S,2R,5R)-2-(2-hydroxypropan-2-yl)-5-methylcyclohexan-1-ol
UNII-90V2FV8O8K
1beta,3alpha,4alpha-p-menthane-3,8-diol
90V2FV8O8K
Cyclohexanemethanol, 2-hydroxy-alpha,alpha,4-trimethyl-, (1R,2S,4R)-
(+/-)-cis-p-Menthane-3,8-diol
(1S,2R,5R)-2-(1-hydroxy-1-methylethyl)-5-methylcyclohexanol
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Neomenthoglycol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9823 98.23%
Caco-2 - 0.5392 53.92%
Blood Brain Barrier + 0.7750 77.50%
Human oral bioavailability + 0.6714 67.14%
Subcellular localzation Mitochondria 0.6312 63.12%
OATP2B1 inhibitior - 0.8424 84.24%
OATP1B1 inhibitior + 0.9673 96.73%
OATP1B3 inhibitior + 0.9523 95.23%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7750 77.50%
BSEP inhibitior - 0.9431 94.31%
P-glycoprotein inhibitior - 0.9687 96.87%
P-glycoprotein substrate - 0.8765 87.65%
CYP3A4 substrate - 0.5852 58.52%
CYP2C9 substrate - 0.8012 80.12%
CYP2D6 substrate - 0.7198 71.98%
CYP3A4 inhibition - 0.8967 89.67%
CYP2C9 inhibition - 0.6604 66.04%
CYP2C19 inhibition - 0.8445 84.45%
CYP2D6 inhibition - 0.9401 94.01%
CYP1A2 inhibition - 0.6966 69.66%
CYP2C8 inhibition - 0.9570 95.70%
CYP inhibitory promiscuity - 0.9403 94.03%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.8700 87.00%
Carcinogenicity (trinary) Non-required 0.6846 68.46%
Eye corrosion - 0.8801 88.01%
Eye irritation + 0.9071 90.71%
Skin irritation + 0.6031 60.31%
Skin corrosion - 0.9128 91.28%
Ames mutagenesis - 0.8216 82.16%
Human Ether-a-go-go-Related Gene inhibition - 0.5923 59.23%
Micronuclear - 1.0000 100.00%
Hepatotoxicity + 0.7500 75.00%
skin sensitisation + 0.6602 66.02%
Respiratory toxicity - 0.7111 71.11%
Reproductive toxicity - 0.5222 52.22%
Mitochondrial toxicity - 0.6250 62.50%
Nephrotoxicity - 0.6920 69.20%
Acute Oral Toxicity (c) III 0.7766 77.66%
Estrogen receptor binding - 0.8679 86.79%
Androgen receptor binding - 0.8596 85.96%
Thyroid receptor binding - 0.6596 65.96%
Glucocorticoid receptor binding - 0.7897 78.97%
Aromatase binding - 0.8600 86.00%
PPAR gamma - 0.8814 88.14%
Honey bee toxicity - 0.9169 91.69%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity + 0.6200 62.00%
Fish aquatic toxicity + 0.8369 83.69%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.56% 97.25%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.63% 97.09%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 86.15% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 84.93% 91.11%
CHEMBL2581 P07339 Cathepsin D 82.30% 98.95%

Cross-Links

Top
PubChem 9920491
NPASS NPC34429
LOTUS LTS0109753
wikiData Q27121112